Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Oncology"
DOI: 10.1093/annonc/mdx790
Abstract: Despite the unheralded success of immune checkpoint blockade in delivering durable responses for some patients with non-small-cell lung cancer (NSCLC), the majority of patients do not respond. PD-L1 tumour expression and pre-existing tumour T-cell infiltration… read more here.
Keywords: building better; research platforms; better translational; lung cancer ... See more keywords